An Interview with Chroma Technology’s President

by VBSA-admin on February 7, 2019

Chroma Technology’s President, Paul Millman, was featured in a recent VT Digger Business & Economy interview:

Vermont economic development officials hold up Chroma as one of the state’s leading success stories. Founded in 1991 by co-workers who left their jobs at Omega Optical to start a competing business, Chroma now employs 140 people and has offices in Europe and Asia.

Paul Millman, Chroma’s co-founder and now its president, recently talked with VTDigger reporter Anne Wallace Allen about Chroma and where it is headed.

Check out the interview here: Q&A with Paul Millman of Chroma

{ 0 comments }

Continuing with our mission to promote success in biomedical entrepreneurship, the I-Trep program offers individual one-to-one consulting with experts to assist in the preparation of proposals and the management of awarded SBIR/STTR Grants.

Assistance is available for the following areas:

1. SBIR/STTR Phase I submission or resubmission

2.  SBIR/STTR Phase II submission or resubmission

3.  Accounting for awarded grants

4.  Compliance assistance for awarded grants

Request for this consultant service is available year-round.  The request will be submitted to the I-Trep administrative office where it will be discussed by the Steering Committee.  If selected, the I-Trep program will put you in contact with an expert to help you with your topic of interest.  The I-Trep program will cover the consultation fee (maximum amount $3500).  While there is no deadline for the requests, awards will be funded on a first come first served basis.  

Click here for the >>>Application

Eva Garland Consulting, LLC

Eva Garland Consulting was founded by Dr. Eva Garland, who excels in securing resources and leading scientific teams to develop innovative new technologies that span the biological and physical sciences.  As Vice President of Research & Development for an early stage biotechnology company, Dr. Garland was awarded over $12 million in grant funding, including twelve SBIR/STTR Awards as well as funding from Foundations and state and local sources. Dr. Garland and her team have secured hundreds of additional grants totaling over $100 million for technologies ranging from pharmaceuticals, wound care products, antiseptics, medical devices, agrochemicals, and industrial products.
http://www.evagarland.com/

Questions?  Contact Mercedes Rincon (mrincon@uvm.edu) or Tina Thornton (tina.thornton@uvm.edu).

Please join us to learn about the drug discovery pipeline! What does it take to get that “potential target for therapy” that you discovered to a marketable product?

Presenter: Alex Abuin, Ph.D.

Monday, December 10th

2-3 PM ET

HSRF 300

http://med.uvm.edu/itrep/webinars


Questions?  Contact Tina Thornton (Tina.Thornton@uvm.edu)

iTREP logo